Hypertension Trial, Recruiting NCT07099677 Sponsor: Abant Izzet Baysal University Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT07099677
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 75 years
  • People who have recently been diagnosed with high blood pressure (hypertension) for the first time
  • People who have not previously taken any medication to lower blood pressure
  • People with no history of neurological, inner ear, bone/joint, or mental health conditions that affect balance
  • People who are able to walk on their own without the use of a walking aid or similar device
  • People who have agreed to take part in the study and signed a consent form

Who may not be able to join:

  • People whose high blood pressure is caused by another underlying medical condition (known as secondary hypertension)
  • People who have been diagnosed with an inner ear disorder, such as BPPV or Ménière's disease
  • People who are currently taking medications that may affect balance, such as sedatives or certain mental health medications
  • People who have had a fall caused by an injury or accident that was not related to a balance problem
  • People who have cognitive difficulties (such as memory or thinking problems) that would prevent them from completing the trial's tests
  • People who would not be able to attend or complete the required check-ups at the two-week and four-week follow-up points

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Alp Ozel, PT, PhD, Abant Izzet Baysal University

Phone: +903742534520

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Abant Izzet Baysal University
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
30 June 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Fall Risk Score (Biodex Balance System)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov